NEUROGEN CORP
S-3, EX-23.2, 2000-07-14
PHARMACEUTICAL PREPARATIONS
Previous: NEUROGEN CORP, S-3, EX-23.1, 2000-07-14
Next: NEUROGEN CORP, S-3, EX-24.1, 2000-07-14



<PAGE>

                                                                    Exhibit 23.2


                        Consent of Independent Auditors

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Neurogen Corporation
for the registration of 1,638,000 shares of common stock and to the
incorporation by reference therein of our report dated February 13, 1998 with
respect to the financial statements of Neurogen Corporation for the year ended
December 31, 1997, included in its Annual Report (Form 10-K) for the year ended
December 31, 1999, filed with the Securities and Exchange Commission.



                                                      ERNST & YOUNG LLP

Boston, Massachusetts
July 12, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission